Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Sanofi SA (ADR) - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
SNY
Nasdaq
2834
https://www.sanofi.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Sanofi SA (ADR)
SanofiĀ Asks Banks to Pitch for $20 Billion OTC Spinoff
- Apr 23rd, 2024 4:27 pm
Sanofi (SNY) Rilzabrutinib Shows Benefit in Blood Disorder Study
- Apr 23rd, 2024 4:03 pm
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
- Apr 23rd, 2024 5:00 am
Market Chatter: Sanofi to Pay More Than $100 Million to Settle 4,000 Suits Alleging Zantac Causes Cancer
- Apr 22nd, 2024 3:40 pm
Sanofi to overhaul US operations of vaccines, cut jobs
- Apr 18th, 2024 8:28 pm
Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis
- Apr 17th, 2024 5:00 am
Sanofi: Information concerning the total number of voting rights and shares - March 2024
- Apr 12th, 2024 6:05 pm
Sanofi - AGM 30.04.2024 - Availability of Preparatory documents
- Apr 8th, 2024 4:00 pm
10 Best Weight Loss Drug Stocks to Buy Now
- Apr 7th, 2024 12:47 am
UPDATE 2-Cyclicals drive modest gains across European stocks
- Apr 4th, 2024 9:00 am
Sanofi to Settle Claims That Heartburn Drug Zantac Caused Cancer
- Apr 3rd, 2024 11:02 pm
UPDATE 2-Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts
- Apr 3rd, 2024 9:40 pm
Why Is Denali Therapeutics (DNLI) Up 2.8% Since Last Earnings Report?
- Mar 28th, 2024 3:30 pm
32 Countries with the Highest Rates of Diabetes
- Mar 26th, 2024 9:10 am
Innate Pharma S.A. (NASDAQ:IPHA) Q4 2023 Earnings Call Transcript
- Mar 22nd, 2024 3:33 pm
Press Release: Availability of the Q1 2024 Memorandum for modelling purposes
- Mar 22nd, 2024 6:30 am
Mirador Therapeutics raises over $400 mln in early funding rounds
- Mar 21st, 2024 11:00 am
Sanofi: Information concerning the total number of voting rights and shares - February 2024
- Mar 15th, 2024 7:04 pm
12 Most Profitable Biotech Stocks To Invest In
- Mar 14th, 2024 1:38 pm
ASLAN (ASLN) Up 161% on Upbeat Initial Data From Eczema Study
- Mar 12th, 2024 1:58 pm
Scroll